International Session (Oral)1

[IO-03] Novel therapies targeting NF-κB signal for triple-negative breast cancer patients with poor prognosis caused by loss of CYLD expression

^○Hitomi Arakaki¹, Akari Kuwano¹, Chika Hirai¹, Chica Saigo², Ayumi Kanemaru¹, Mitsuhiro Hayashi³, Hideyuki Saito^1,2, Yuki Narita^1,2, Hirofumi Jono^1,2 (1.Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 2.Department of Pharmacy, Kumamoto University Hospital, 3.Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University)